Skip to main content
Top
Published in: International Journal of Hematology 2/2009

01-03-2009 | Original Article

Fibronectin promotes the phorbol 12-myristate 13-acetate-induced macrophage differentiation in myeloid leukemia cells

Authors: Gunes Esendagli, Hande Canpinar, Guldal Yilmaz, F. Figen Kaymaz, Emin Kansu, Dicle Guc

Published in: International Journal of Hematology | Issue 2/2009

Login to get access

Abstract

The extracellular matrix plays a critical role in macrophage maturation. In this study, the HL60 cell line was used as a model of leukemic myeloid cell differentiation. We assessed the ability of HL60 cells cultured on fibronectin substratum prior to phorbol 12-myristate 13-acetate (PMA) induction to differentiate into terminally differentiated macrophages. Beside their distinctive macrophage morphology, they expressed antigen receptors CD14, TLR2, TLR4 and CD68, and displayed enhanced phagocytic activity and production of reactive oxygen species. Expression of CD13, CD33, CD15 and α-naphthyl-acetate esterase was also maintained, however, differentiated HL60 cells were HLA-DR and CD1a negative. Here, we describe the enhanced capacity of fibronectin-adherent HL60 cells to differentiate into macrophages in response to PMA.
Literature
2.
go back to reference Trayner ID, Bustorff T, Etches AE, Mufti GJ, Foss Y, Farzaneh F. Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, alpha1, 25 dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate. Leuk Res. 1998;22:537–47. doi:10.1016/S0145-2126(98)00041-1.CrossRefPubMed Trayner ID, Bustorff T, Etches AE, Mufti GJ, Foss Y, Farzaneh F. Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, alpha1, 25 dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate. Leuk Res. 1998;22:537–47. doi:10.​1016/​S0145-2126(98)00041-1.CrossRefPubMed
4.
go back to reference Manfredini R, Balestri R, Tagliafico E, Trevisan F, Pizzanelli M, Grande A, et al. Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells. Blood. 1997;89:135–45.PubMed Manfredini R, Balestri R, Tagliafico E, Trevisan F, Pizzanelli M, Grande A, et al. Antisense inhibition of c-fes proto-oncogene blocks PMA-induced macrophage differentiation in HL60 and in FDC-P1/MAC-11 cells. Blood. 1997;89:135–45.PubMed
5.
go back to reference Kazanietz MG. Targeting protein kinase C and “non-kinase” phorbol ester receptors: emerging concepts and therapeutic implications. Biochim Biophys Acta. 2005;1754:296–304.CrossRefPubMed Kazanietz MG. Targeting protein kinase C and “non-kinase” phorbol ester receptors: emerging concepts and therapeutic implications. Biochim Biophys Acta. 2005;1754:296–304.CrossRefPubMed
6.
go back to reference Bohnsack JF, Chang J. Activation of beta 1 integrin fibronectin receptors on HL60 cells after granulocytic differentiation. Blood. 1994;83:543–52.PubMed Bohnsack JF, Chang J. Activation of beta 1 integrin fibronectin receptors on HL60 cells after granulocytic differentiation. Blood. 1994;83:543–52.PubMed
7.
go back to reference Canpinar H, Esendagli G, Kansu E, Gunel-Ozcan A, Guc D. Adhesion of beta1 integrin to fibronectin regulates CAM-DR phenotype via p21WAF1/cip1 in HL60 acute myeloid leukemia (AML) Cells. Turk J Med Sci. 2008;38:97–104. Canpinar H, Esendagli G, Kansu E, Gunel-Ozcan A, Guc D. Adhesion of beta1 integrin to fibronectin regulates CAM-DR phenotype via p21WAF1/cip1 in HL60 acute myeloid leukemia (AML) Cells. Turk J Med Sci. 2008;38:97–104.
9.
go back to reference Rook GA, Steele J, Umar S, Dockrell HM. A simple method for the solubilisation of reduced NBT and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J Immunol Methods. 1985;82:161–7. doi:10.1016/0022-1759(85)90235-2.CrossRefPubMed Rook GA, Steele J, Umar S, Dockrell HM. A simple method for the solubilisation of reduced NBT and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J Immunol Methods. 1985;82:161–7. doi:10.​1016/​0022-1759(85)90235-2.CrossRefPubMed
11.
go back to reference Abbas AK, Lichtman AH, Pober JS. Innate immunity In: Cellular and molecular immunology. Philadelphia: WB Saunders Co; 2003. p. 275. Abbas AK, Lichtman AH, Pober JS. Innate immunity In: Cellular and molecular immunology. Philadelphia: WB Saunders Co; 2003. p. 275.
13.
go back to reference Gaté L, Lunk A, Tew KD. Resistance to phorbol 12-myristate 13-acetate-induced cell growth arrest in an HL60 cell line chronically exposed to a glutathione S-transferase pi inhibitor. Biochem Pharmacol. 2003;65:1611–22. doi:10.1016/S0006-2952(03)00152-7.CrossRefPubMed Gaté L, Lunk A, Tew KD. Resistance to phorbol 12-myristate 13-acetate-induced cell growth arrest in an HL60 cell line chronically exposed to a glutathione S-transferase pi inhibitor. Biochem Pharmacol. 2003;65:1611–22. doi:10.​1016/​S0006-2952(03)00152-7.CrossRefPubMed
17.
go back to reference Riedy MC, Stewart CC. Characterization of human monocytes/macrophages. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current protocols in immunology. New York: Wiley; 1994. supplement 11. Riedy MC, Stewart CC. Characterization of human monocytes/macrophages. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, editors. Current protocols in immunology. New York: Wiley; 1994. supplement 11.
18.
go back to reference Collins SJ. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 1987;70:1233–44.PubMed Collins SJ. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 1987;70:1233–44.PubMed
Metadata
Title
Fibronectin promotes the phorbol 12-myristate 13-acetate-induced macrophage differentiation in myeloid leukemia cells
Authors
Gunes Esendagli
Hande Canpinar
Guldal Yilmaz
F. Figen Kaymaz
Emin Kansu
Dicle Guc
Publication date
01-03-2009
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 2/2009
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-008-0243-8

Other articles of this Issue 2/2009

International Journal of Hematology 2/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine